Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Deaths from Leukemia

Leukemia: Deaths

Deaths from Leukemia: 21,014 deaths reported in USA 1999 (NVSR Sep 2001)

Death Rate Extrapolation

Death rate extrapolations for USA for Leukemia: 21,013 per year, 1,751 per month, 404 per week, 57 per day, 2 per hour, 0 per minute, 0 per second. Note: this automatic extrapolation calculation uses the deaths statistic: 21,014 deaths reported in USA 1999 (NVSR Sep 2001)

Survival rate statistics for Leukemia

The following are statistics from various sources about the survival rate for Leukemia:

  • 48% of white people survive 5 years for leukemia in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 39% of African American people survive 5 years for leukemia in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 46% survive 5 years for leukemia in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 38.3% of people with Leukemia survive after 5 years in the US 1983-90 (SEER)
  • 5-year survival rate for black people with leukaemia is 30.8% in the US 1983-90 (SEER)
  • 5-year survival rate for people with leukaemia is 38.3% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with leukaemia is 39.5% in the US 1983-90 (SEER)
  • 5-year survival rate for white children under 15-years old with acute lymphocytic leukaemia is 75.0% in the US 1983-90 (SEER)
  • 5-year survival rate for white children under 15-years old with acute myeloid leukaemia is 29.4% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with leukaemia is 57.4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with leukaemia is 32% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with leukaemia is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with leukaemia is 47% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with leukaemia is 76% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with leukaemia is 51% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with leukaemia is 72% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with leukaemia is 47% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with leukaemia is 64% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with leukaemia is 36% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with leukaemia is 52% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with leukaemia is 26% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with leukaemia is 38% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with leukaemia is 17% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with leukaemia is 55.5% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with leukaemia is 33.6% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with leukaemia is 74% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with leukaemia is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with leukaemia is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with leukaemia is 42% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with leukaemia is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with leukaemia is 45% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with leukaemia is 62% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with leukaemia is 41% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with leukaemia is 51% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with leukaemia is 28% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with leukaemia is 38% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with leukaemia is 19% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 3 to 5 years is the life expectancy after diagnosis of chronic myelogenous leukemia if no treatment or transplant is done (MPD Research Centre, Association of Online Cancer Resources)
  • 20% of chronic myelogenous leukemia patients has a relapse during the first five years after a transplant (MPD Research Centre, Association of Online Cancer Resources)
  • 50% of chronic myelogenous leukemia patients will be in remission at 8 years if they receive a transplant within one year of being diagnosed as in the chronic phase (MPD Research Centre, Association of Online Cancer Resources)

Misdiagnosis and Leukemia deaths

Leukemia can be deadly if misdiagnosed...more »

Death statistics for Leukemia

The following are statistics from various sources about deaths and Leukemia:

  • 23,300 estimated deaths for leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 12,900 estimated male deaths for leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 10,310 estimated female deaths for leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 1,300 deaths in men from leukemia in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 990 deaths in women from leukemia in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 8 per 100,000 deaths in men from leukemia in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 4 per 100,000 deaths in women from leukemia in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 1,450 estimated deaths for Acute Lymphocytic Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 820 estimated male deaths for Acute Lymphocytic Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 630 estimated female deaths for Acute Lymphocytic Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 4,800 estimated deaths for Chronic Lymphocytic Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 2,730 estimated male deaths for Chronic Lymphocytic Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 2,070 estimated female deaths for Chronic Lymphocytic Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 8,870 estimated deaths for Acute Myeloid Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 4,810 estimated male deaths for Acute Myeloid Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 4,060 estimated female deaths for Acute Myeloid Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 1,570 estimated deaths for Chronic Myeloid Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 940 estimated male deaths for Chronic Myeloid Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 630 estimated female deaths for Chronic Myeloid Leukemia in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Mortality rates for leukemia deaths in various countries:
    • 6.6 men per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.2 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.7 men per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.8 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.0 men per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.6 women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.0 men per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.7 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.2 men per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.2 men per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.0 men per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.0 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.8 men per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.0 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 men per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.5 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.8 men per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.6 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.7 men per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.4 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.7 men per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 men per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.1 men per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.7 men per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.3 men per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.8 men per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.6 men per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.9 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.4 men per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.5 men per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.5 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.1 men per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.6 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 men per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.5 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.1 men per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.0 men per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000196.7 American Cancer Society)
    • 4.0 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.7 men per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.8 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.3 men per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.7 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.4 men per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.0 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.9 men per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.0 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.0 men per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.3 men per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.4 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.6 men per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.6 men per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.5 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.1 men per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.4 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.2 men per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.5 men per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.0 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.0 men per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.4 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.1 men per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.7 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.9 men per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.4 men per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.1 men per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.4 men per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.1 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.6 men per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.4 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.9 men per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 men per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • 0.9% of all female deaths was due to leukaemia in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 1.2% of all male deaths was due to leukaemia in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 581 women died from leukaemia in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 843 men died from leukaemia in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Estimated 60,400 deaths in the USA 2004 for leukemia/lymphoma/myeloma (The Leukemia and Lymphoma Society Web Site, 2004)
  • 1 death occurs every 9 minutes in the USA for leukemia/lymphoma/myeloma (The Leukemia and Lymphoma Society Web Site, 2004)
  • Estimated 640,000 people in the USA with leukemia/lymphoma/myeloma (The Leukemia and Lymphoma Society Web Site, 2004)
  • 266 deaths for leukemia in New Zealand 1999 (New Zealand Health Information, 2002)

Deaths from Leukemia: medical news summaries

The following medical news items are relevant to death from Leukemia:

Leukemia: Hospitalization Statistics

The following are statistics from various sources about hospitalizations and Leukemia:

  • 0.37% (46,787) of hospital consultant episodes were for lymphoid leukaemia in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 97% of hospital consultant episodes for lymphoid leukaemia required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 62% of hospital consultant episodes for lymphoid leukaemia were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 38% of hospital consultant episodes for lymphoid leukaemia were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • more stats »

Premium articles about Death:

This section lists our premium articles on topics related to death. These are original authored articles on topics of great interest:

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise